Insider · CIK 0001971724
Shawn Canter
Files at KULR (KULR Technology Group, Inc.). First filing -, latest -.
In brief
Shawn Canter files SEC Form 4 as CFO and director at KULR (KULR Technology Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Shawn Canter has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | KULR KULR Technology Group, Inc. | FTax withholding Common Stock | -19,369 | $2.17 | $42k | 326,978 | Apr 17, 2026 |
| Jan 21, 2026 | KULR KULR Technology Group, Inc. | FTax withholding Common Stock | -16,170 | $4.18 | $68k | 346,347 | Jan 23, 2026 |
| Mar 31, 2025 | KULR KULR Technology Group, Inc. | FTax withholding Common Stock | -99,857 | $1.46 | $146k | 500,143 | Apr 2, 2025 |
| Jan 16, 2025 | KULR KULR Technology Group, Inc. | AGrant or award Common Stock | +1,500,000 | $0.00 | $0 | 3,000,000 | Jan 17, 2025 |
Questions about Shawn Canter
Answered from the filings on this page, as of the latest one.
Is Shawn Canter buying or selling?
Shawn Canter has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Shawn Canter's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shawn Canter has 0.
Where does Shawn Canter file Form 4?
Shawn Canter has filed Form 4 at KULR (KULR Technology Group, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.